What Are Peptides? Types, Functions and Evidence

NextGen Peptides Research Library

Peptide fundamentals | 6 min read | Updated October 16, 2026

What are peptides, and what do peptides actually do? The short answer is that peptides are molecules built from amino acids joined by peptide bonds. The useful answer is more specific: different peptide sequences can have very different roles, from biological signalling to serving as materials for laboratory experiments. The word peptide describes chemistry, not a guaranteed benefit.

This guide from NextGen Peptides explains the main categories, why collagen peptides and receptor-targeting molecules are not interchangeable, and how to separate a genuine research finding from a broad marketing claim.

Research and educational use only. This article is not medical advice, dosing guidance, or a recommendation for human or veterinary use. Published findings do not establish clinical benefits or suitability for research-use catalog products.

At a glance

• Peptides are not one treatment category. Their sequence, structure and experimental context matter.
• Natural does not mean harmless. A biological signal can have powerful effects, and a synthetic analogue is not automatically equivalent to the body's own molecule.
• Evidence belongs to the exact material studied. Results cannot be transferred freely between sequences, mixtures, formulations or routes of administration.
• Purity and clinical evidence answer different questions. A laboratory certificate is not a clinical trial or a regulatory authorization.

What is a peptide?

Amino acids are molecular building units. Joining them through peptide bonds creates a chain with a particular order, called its sequence. IUPAC's chemical definition covers compounds made from two or more amino-acid units through these bonds. A dipeptide contains two units; a tripeptide contains three. Longer chains can form polypeptides and proteins, with terminology depending on context rather than one universal length cutoff. [1]

Sequence is not a minor label detail. Changing the order of units, modifying an end of the chain, or using only a fragment changes the material being discussed. A product name alone is therefore an incomplete scientific description. For research, the identity and composition of the actual sample need to match the question being investigated.

What do peptides do in the body?

Some peptides act as signals. They interact with biological targets and influence a response in particular cells. One well-established example is glucagon-like peptide-1, or GLP-1, which participates in the response to nutrients.

In a 1987 human physiology experiment, Kreymann and colleagues found that circulating GLP-1 rose after food or oral glucose. In a small controlled infusion experiment, the peptide affected insulin and glucose responses. This was evidence for the activity of a specific molecule under specific conditions, not proof that all peptides share those effects. [2]

That distinction explains why a useful question is not simply "Do peptides work?" It is "Which peptide, interacting with which target, in which study, and measured against what outcome?"

The main categories people often confuse

1. Food-derived peptides

Collagen hydrolysates contain mixtures of fragments produced by breaking down collagen. They are not the same material as a single, sequence-defined research peptide. Iwai and colleagues identified several collagen-derived peptides in human blood after participants ingested gelatin hydrolysates. That study demonstrated absorption of particular fragments; it did not establish every claim made for collagen supplements. [3]

2. Endogenous signals and their analogues

An endogenous molecule is one the body produces. An analogue is a related but modified molecule. Similar names do not establish identical duration, target activity, safety or clinical effects. Evidence must follow the specific molecule and formulation, not just the general pathway.

3. Peptide-based medicines studied in clinical trials

Some defined peptide-based medicines have been evaluated in large randomized human studies. For example, the STEP 1 semaglutide trial investigated weight-related outcomes in adults without diabetes. It studied a controlled medicinal formulation with a defined protocol, not an arbitrary online vial bearing the same ingredient name. [4]

4. Laboratory research compounds

Other materials are investigated primarily in biochemical, cell or animal experiments. A 2011 BPC-157 study examined rat tendon explants and tendon-derived cells, including cell migration and survival under stress. These are meaningful experimental observations, but they are not evidence that a retail research product treats a human tendon injury. [5]

How to read peptide benefits and side-effect claims

Start with the study's design rather than its headline. A cell experiment can help explain a mechanism; an animal study can test a biological hypothesis; a randomized human trial can evaluate a defined intervention in a defined population. These forms of evidence answer different questions.

• Identify the model. Was the result measured in a dish, an animal or human participants?
• Identify the material. Was it the full sequence, a fragment, an analogue or a blend?
• Identify the outcome. A change in a laboratory marker is not automatically a change in symptoms or long-term health.
• Read the limitations. Look for the comparator, sample size, follow-up, adverse events, funding and uncertainty.

Our guide to reading peptide research and spotting red flags expands this checklist.

What can a peptide COA tell you?

A Certificate of Analysis describes tests performed on a submitted sample. Depending on the methods and scope, it may report identity, chromatographic purity or measured peptide content. Those are separate measurements. A high HPLC peak-area percentage does not, by itself, establish the amount of peptide in a vial.

USP researchers describe the need to account for factors such as water, counterions and other impurities when characterizing peptide reference materials. Their work illustrates why identity, purity and content require appropriate analytical methods. It does not mean that every material with a COA is USP-certified. Nor does a chemical purity result establish sterility, clinical efficacy or approval. [6]

For practical checks, see our COA verification guide and the batch-documentation library.

What should Canadian readers check?

In its April 2026 advisory, Health Canada states that research-use-only wording does not exempt unauthorized peptide drugs from regulatory requirements. For a medicine's authorization status, use the Drug Product Database, not a seller's certificate or research label. [7]

Common questions

Are collagen peptides and research peptides the same?

No. A food-derived mixture and a sequence-defined laboratory material should not be treated as interchangeable. Their composition, intended context and supporting evidence differ.

Does higher purity mean stronger benefits?

No. Purity is an analytical characteristic. A benefit claim requires suitable evidence for the exact intervention and outcome being claimed.

Which peptide is best?

There is no scientifically meaningful universal ranking. For research, start with the biological question, then examine the specific material, methods and evidence. For personal health decisions, consult a licensed healthcare professional.

Bottom line

Peptides are a diverse family of molecules, not a shortcut to one set of benefits. Understanding sequence, research context, evidence quality and documentation is more useful than choosing by a trend or a headline. Continue with what human weight-loss trials actually show or explore the Research Library.

Sources

1. IUPAC Gold Book. Peptides. DOI: 10.1351/goldbook.P04479.
2. Kreymann B et al. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet. 1987. DOI: 10.1016/S0140-6736(87)91194-9.
3. Iwai K et al. Identification of food-derived collagen peptides in human blood after oral ingestion of gelatin hydrolysates. J Agric Food Chem. 2005. DOI: 10.1021/jf050206p.
4. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021. DOI: 10.1056/NEJMoa2032183.
5. Chang CH et al. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011. DOI: 10.1152/japplphysiol.00945.2010.
6. McCarthy D et al. Reference Standards to Support Quality of Synthetic Peptide Therapeutics. Pharm Res. 2023. DOI: 10.1007/s11095-023-03493-1.
7. Health Canada. Advisory on unauthorized injectable peptide drugs. April 9, 2026.

Editorial standard: Prepared by NextGen Peptides for research education. Primary studies and official sources are linked above. Laboratory findings, clinical evidence and product documentation are kept separate. The featured image is an AI-generated conceptual illustration, not a verified molecular model. For corrections, contact orders@nextgenpeptides.ca.